Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Reversion of the Experimental Hemodilutional Coagulopathy Induced by Crystalloids and Colloids Using Different Coagulation Factor Concentrates

Carolina Caballo, Ana M Galan, Ph.D., Maribel Diaz-Ricart, PhD, Irene Lopez-Vilchez, Ph.D., Miguel Lozano, MD, PhD, Joan Cid, MD, PhD, Marcos Pino, Joan Beltran, MD, PhD, Misericordia Basora, MD, PhD, Arturo Pereira, MD. PhD, Gines Escolar, MD, PhD

Blood (2011) 118 (21): 4349.

https://doi.org/10.1182/blood.V118.21.4349.4349

Published: 2011

Journal Articles

Impact of Pathogen Reduction Technology Treatment and Storage in New Generation Platelet Additive Solutions (PAS) on Platelet Function.

Gines Escolar, MD, PhD, Miguel Lozano, MD, PhD, Patricia Molina, Susanne Marschner, Ph.D., Raymond Goodrich, PhD, Ana M. Galan, Ph.D.

Blood (2009) 114 (22): 2115.

https://doi.org/10.1182/blood.V114.22.2115.2115

Published: 2009

Journal Articles

Platelets come back in from the cold

Miguel Lozano

Blood (2008) 111 (6): 2951.

https://doi.org/10.1182/blood-2008-01-131920

Published: 2008

Journal Articles

Leucocyte-Reduced Buffy Coat Platelet Concentrates (BCPC) Treated with INTERCEPT™ Stored up to 7 Days: Hemostatic Function in a Whole Blood Flow System.

Miguel Lozano, MD, PhD, Ana Galan, PhD, Roberto Mazzara, MD, PhD, Laurence Corash, MD, Gines Escolar, MD, PhD

Blood (2005) 106 (11): 956.

https://doi.org/10.1182/blood.V106.11.956.956

Published: 2005

Journal Articles

Effects of a New Pathogen-Reduction Technology (Mirasol PRT) on Platelet Function.

Maribel Diaz-Ricart, Ph.D., Silvia Perez-Pujol, Raul Tonda, Miguel Lozano, M.D., Ph.D., Berta Fuste, Irene Lopez-Vilchez, Ana M. Galan, Ph.D., Junzhi Li, Raymond Goodrich, Gines Escolar, M.D., Ph.D.

Blood (2004) 104 (11): 3633.

https://doi.org/10.1182/blood.V104.11.3633.3633

Published: 2004

NARROW

Reversion of the Experimental Hemodilutional Coagulopathy Induced by Crystalloids and Colloids Using Different Coagulation Factor Concentrates

Impact of Pathogen Reduction Technology Treatment and Storage in New Generation Platelet Additive Solutions (PAS) on Platelet Function.

Platelets come back in from the cold

Leucocyte-Reduced Buffy Coat Platelet Concentrates (BCPC) Treated with INTERCEPT™ Stored up to 7 Days: Hemostatic Function in a Whole Blood Flow System.

Effects of a New Pathogen-Reduction Technology (Mirasol PRT) on Platelet Function.

Email alerts

ASH Publications

American Society of Hematology

Reversion of the Experimental Hemodilutional Coagulopathy Induced by Crystalloids and Colloids Using Different Coagulation Factor Concentrates

Impact of Pathogen Reduction Technology Treatment and Storage in New Generation Platelet Additive Solutions (PAS) on Platelet Function.

Platelets come back in from the cold

Leucocyte-Reduced Buffy Coat Platelet Concentrates (BCPC) Treated with INTERCEPT™ Stored up to 7 Days: Hemostatic Function in a Whole Blood Flow System.

Effects of a New Pathogen-Reduction Technology (Mirasol PRT) on Platelet Function.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only